Arkolith/Insider Trading/HGEN/Form 4

Chappell Dale

Chief Scientific Officer, Director, 10% OwnerHUMANIGEN, INC (HGEN) · full profile →Form 4 · filed Oct 4, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 30, 2021Grant(A)23K—$023K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-21-010216) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML